首页 | 本学科首页   官方微博 | 高级检索  
检索        

应用CD3AK细胞预防肝癌术后复发的初步观察
引用本文:莫钦国,梁安民,洪坚善,袁卫平,杨南武.应用CD3AK细胞预防肝癌术后复发的初步观察[J].广西医科大学学报,1999,16(5):582-583.
作者姓名:莫钦国  梁安民  洪坚善  袁卫平  杨南武
作者单位:广西医科大学附瘤肿瘤医院,南宁,530021
基金项目:广西自然科学基金;9532028;
摘    要:目的 观察CD3AK细胞治疗对肝癌术后复发的影响。方法 62例肝癌切除术按序列单双数的原则分为两组,研究组32例术后1周开始应用CD3AK细胞治疗,每隔2~3个月施行一疗程,共2~6个疗程;对照组30例术后不用CD3AK细胞治疗,仅作一般护治疗。结果 ①研究组术后1年复发率6.3%(2/32)明显低于对照组26.7%(8/30)(P〈0.05);②研究组和对照组术后4周免疫功能有明显差异(P〈0.

关 键 词:肝肿瘤  肝切除术  CD3AK细胞  复发
修稿时间::1999-03-01

THE EFFECTS OF CD3AK CELLS THERAPY ON POSTOPERATIVE RECURRENT RATE OF HEPATOCELLULAR CARCINOMA (HCC)
Mo Qinguo,Liang Anmin,Hong Jianshan,et al.THE EFFECTS OF CD3AK CELLS THERAPY ON POSTOPERATIVE RECURRENT RATE OF HEPATOCELLULAR CARCINOMA (HCC)[J].Journal of Guangxi Medical University,1999,16(5):582-583.
Authors:Mo Qinguo  Liang Anmin  Hong Jianshan  
Abstract:Objective : To observe the effects of CD 3AK cells therapy on postoperative recurrent rate of HCC Methods :62 cases with HCC were divided into two groups,and the experimental group of 32 cases with HCC were treated by CD 3AK cells after hepatic resection The control group of 30 cases with HCC were treated only by hepatic resection Result : The 1 year recurrent rate of experimental group ( 6 3% ) was significantly lower than that of control group (26 7%) Conclusion :The result indicated that CD 3AK cells therapy for HCC is an approach to prevent recurrence after hepatic resection
Keywords:liver neoplasms  hepatectomy  CD  3AK cell  recurrence
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号